智通财经APP讯，达安基因(002030.SZ)发布公告，近日，公司下属控股子公司广州市达瑞生物技术股份有限公司取得国家药品监督管理局颁发的医疗器械注册证一个，医疗器械名称:梅毒螺旋体抗体检测试剂盒(化学发光免疫分析法)，注册证编号：国械注准20253400374。有效期自批准之日起至2030年2月10日。预期用途：本试剂盒用于体外定性检测人血清或血浆中的梅毒螺旋体抗体。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.